Back to Oregon

SB1031 • 2025

Requires a physician who prescribes drugs for a chemical abortion to provide certain information to a person to whom such drugs are prescribed.

Requires a physician who prescribes drugs for a chemical abortion to provide certain information to a person to whom such drugs are prescribed.

Abortion
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Senator Weber, Senator Robinson,, Smith DB
Last action
2025-06-27
Official status
In Senate Committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Requires a physician who prescribes drugs for a chemical abortion to provide certain information to a person to whom such drugs are prescribed.

Digest: The Act tells doctors that they have to tell a patient who gets a chemical abortion about how to reverse the process.

What This Bill Does

  • Digest: The Act tells doctors that they have to tell a patient who gets a chemical abortion about how to reverse the process.
  • (Flesch Readability Score: 65.2).
  • Requires a physician who prescribes drugs for a chemical abortion to provide certain information to a person to whom such drugs are prescribed.
  • Requires the Oregon Health Authority to publish, on a website developed and maintained by the authority, specified information regarding the possible reversal of a chemical abortion.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2025-06-27 Senate

    In committee upon adjournment.

  2. 2025-02-18 Senate

    Introduction and first reading. Referred to President's desk.

  3. 2025-02-18 Senate

    Referred to Health Care.

Official Summary Text

Digest: The Act tells doctors that they have to tell a patient who gets a chemical abortion about how to reverse the process. (Flesch Readability Score: 65.2).
Requires a physician who prescribes drugs for a chemical abortion to provide certain information to a person to whom such drugs are prescribed. Requires the Oregon Health Authority to publish, on a website developed and maintained by the authority, specified information regarding the possible reversal of a chemical abortion. Allows specified persons to bring a cause of action for actual and punitive damages.
Takes effect on the 91st day following adjournment sine die.
Relating to: Relating to abortion; prescribing an effective date.
Current location: In Senate Committee

Current Bill Text

Read the full stored bill text
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
Senate Bill 1031
Sponsored by Senator WEBER
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced. The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act tells doctors that they have to tell a patient who gets a chemical abortion about
how to reverse the process. (Flesch Readability Score: 65.2).
Requires a physician who prescribes drugs for a chemical abortion to provide certain informa-
tion to a person to whom such drugs are prescribed. Requires the Oregon Health Authority to pub-
lish, on a website developed and maintained by the authority, specified information regarding the
possible reversal of a chemical abortion. Allows specified persons to bring a cause of action for ac-
tual and punitive damages.
Takes effect on the 91st day following adjournment sine die.
A BILL FOR AN ACT
Relating to abortion; and prescribing an effective date.
Be It Enacted by the People of the State of Oregon:
SECTION 1.
As used in sections 1 to 7 of this 2025 Act:
(1) “Abortion” means the use or prescription of a drug, instrument, medicine or other
substance or device to intentionally terminate the pregnancy of a person known to be preg-
nant with a purpose other than:
(a) After viability, to produce a live birth and preserve the life and health of the child
born alive; or
(b) To remove a dead unborn child.
(2) “Chemical abortion” means the use or prescription of an abortion-inducing drug dis-
pensed with the intent to cause the death of an unborn child.
(3)(a) “Medical emergency” means a condition that, in reasonable medical judgment, so
complicates the medical condition of the pregnant person as to necessitate the immediate
termination of the pregnancy to avert the person’s death or for which a delay will create
serious risk of substantial and irreversible physical impairment of a major bodily function,
not including psychological or emotional functions.
(b) “Medical emergency” does not include a claim that the pregnant person will engage
in conduct that would result in the person’s death or in substantial and irreversible physical
impairment of a major bodily function.
SECTION 2.
(1) Except in the case of a medical emergency, a chemical abortion involving
the administration of mifepristone and misoprostol may not be performed or induced, or at-
tempted to be performed or induced, unless the prescribing physician or an agent of the
prescribing physician informs, in person or by telephone, the pregnant person to whom the
drugs described in this subsection are prescribed, at least 24 hours in advance of the chem-
ical abortion, that:
(a) There is a possibility of reversing a chemical abortion after the administration of
NOTE: Matter in boldfaced type in an amended section is new; matter [ italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 3750
SB 1031
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
mifepristone if the person who is pregnant changes the person’s mind, but that time is of
the essence; and
(b) A website developed and maintained by the Oregon Health Authority, as described in
section 3 of this 2025 Act, provides further information on and assistance in the reversal of
a chemical abortion following the administration of mifepristone.
(2) Following the dispensation of mifepristone, the prescribing physician or agent of the
prescribing physician shall provide to the person to whom mifepristone was prescribed the
following written statement:
Recent developing research has indicated that mifepristone alone is not always effective
in ending a pregnancy. It may be possible to avoid, to cease, or even to reverse the intended
effects of a chemical abortion using mifepristone if the second pill, misoprostol, has not been
taken. Please consult with a knowledgeable health care provider regarding the abortion pill
reversal or call the Abortion Pill Reversal Hotline at (877) 558-0333 or visit
https://www.abortionpillreversal.com as soon as possible.
(3) A civil penalty may not be imposed on a physician for failure to comply with sub-
section (1)(b) of this section if the website or information described in subsection (1)(b) of
this section is not available at the time the physician or physician’s agent is required to
provide the information to the pregnant person.
SECTION 3. (1)(a) The Oregon Health Authority shall develop and maintain a website
that, to the extent reasonably practicable, is safeguarded from having the content of the
website altered by a person other than the authority. The authority shall use the website to
provide the information described in subsection (2) of this section.
(b) Information regarding individuals who use or view the website may not be collected
or maintained.
(c) The authority shall monitor the website daily to prevent and correct tampering.
(d) The website must be maintained at a minimum resolution of 70 dots per inch. Any
images appearing on the website must be a minimum of 200 x 300 pixels, and the font size
used on the website must be a minimum of 12 points. All information and images on the
website must be accessible with an industry-standard Internet browser and may not require
additional plug-ins.
(2) The authority shall publish, on the website described in subsection (1) of this section,
materials designed to inform a pregnant person of the possibility of reversing the effects of
a chemical abortion if the person no longer wishes to complete the chemical abortion and
information about and assistance with resources available to reverse the effects of a chemi-
cal abortion.
(3) The information described in subsection (2) of this section must be:
(a) Published in English and in each language that is the primary language of two percent
or more of the state’s population; and
(b) Easily comprehensible.
SECTION 4.
If a medical emergency requires the performance of an abortion, the physi-
cian who performs the abortion shall, prior to the performance of the abortion if possible,
[2]
SB 1031
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
inform the pregnant person upon whom the abortion is to be performed of the medical indi-
cations supporting the physician’s judgment that an abortion is necessary to avert the
person’s death or that a delay of 24 hours or more will create a serious risk of substantial
and irreversible physical impairment of a major bodily function, not including psychological
or emotional conditions.
SECTION 5.
A penalty may not be assessed against the person upon whom an abortion
is performed or induced, or attempted to be performed or induced, in violation of section 2
or 4 of this 2025 Act.
SECTION 6. (1)(a) Except as provided in paragraph (b) of this subsection, the following
persons may maintain an action against the person who performed or induced an abortion,
or attempted to perform or induce an abortion, in violation of section 2 or 4 of this 2025 Act
for actual, economic, noneconomic or punitive damages:
(A) The person upon whom the abortion was performed or induced, or attempted to be
performed or induced;
(B) The person responsible for the fertilization that resulted in the pregnancy that is the
subject of the abortion; or
(C) A grandparent of the unborn child that would have been born but for the abortion if
the person described in subparagraph (A) of this paragraph was under 18 years of age at the
time of the abortion or died as a result of the abortion.
(b) Damages may not be awarded under this subsection if the pregnancy described in
paragraph (a)(B) of this subsection was the result of criminal conduct by the person main-
taining the action described in paragraph (a)(B) of this subsection.
(2) If the plaintiff prevails in the action described in this section, the court shall also
award reasonable attorney fees to the plaintiff.
SECTION 7. (1) In any action brought under section 6 of this 2025 Act, the court shall
determine whether the identity of the person upon whom an abortion was performed must
be exempt from public disclosure under ORS 192.311 to 192.478 if the person does not consent
to disclosure.
(2) If the court determines that the person’s anonymity must be preserved, the court
shall issue orders to the parties, witnesses and counsel, direct the sealing of the record and
order exclusion from the courtroom of all persons who are not parties, witnesses or counsel.
The orders described in this subsection must be accompanied by written findings that explain
why the person’s anonymity must be preserved, why the orders are essential to that end,
how the orders are narrowly tailored to serve that interest and why no reasonable less-
restrictive alternative exists.
(3) If the person described in subsection (1) of this section does not consent to disclose
the person’s identity, any person other than a public official who brings an action under
section 6 of this 2025 Act that is related to the person’s pregnancy shall bring the action
under a pseudonym.
(4) This section shall not be construed to conceal the identity of the plaintiff or witnesses
from the defendant or defendant’s counsel.
SECTION 8.
This 2025 Act takes effect on the 91st day after the date on which the 2025
regular session of the Eighty-third Legislative Assembly adjourns sine die.
[3]